{"DataElement":{"publicId":"7765137","version":"1","preferredName":"Baseline Neoplasm Measurable Other Lesion Specify","preferredDefinition":"Other type of baseline measurable lesion","longName":"TR_TRORRES_MEASTYPO","context":"AMC","contextVersion":"1","DataElementConcept":{"publicId":"3853563","version":"2","preferredName":"Baseline Neoplasm Measurable","preferredDefinition":"A starting point to which things may be compared._A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias._Capable of being measured.","longName":"5946392v1.0:4749015v1.0","context":"NCI Standards","contextVersion":"1","ObjectClass":{"publicId":"5946392","version":"1","preferredName":"Baseline Neoplasm","preferredDefinition":"A starting point to which things may be compared.:A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","longName":"C25213:C3262","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Baseline","conceptCode":"C25213","definition":"A starting point to which things may be compared.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"580DC567-72BD-688B-E053-F662850AD4CF","latestVersionIndicator":"Yes","beginDate":"2017-08-31","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-08-31","modifiedBy":"ONEDATA","dateModified":"2017-08-31","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"4749015","version":"1","preferredName":"Measurable","preferredDefinition":"Capable of being measured.","longName":"C37894","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Measurable","conceptCode":"C37894","definition":"Capable of being measured.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"11B7F26E-16C5-C446-E050-BB89AD434A25","latestVersionIndicator":"Yes","beginDate":"2015-03-20","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2015-03-20","modifiedBy":"ONEDATA","dateModified":"2015-03-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008550","version":"1","preferredName":"Disease Response","preferredDefinition":"the response criteria (includes RECIST and others) and associated documentation of disease.","longName":"DZ_RESP","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22C0651-216B-5273-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NCI CRF Standards","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"580DC567-7299-688B-E053-F662850AD4CF","latestVersionIndicator":"Yes","beginDate":"2013-08-12","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-08-31","modifiedBy":"TAYLORT","dateModified":"2017-08-31","changeDescription":"8/31/17 tt DEC versioned for concept, long name change; transferred Context, added CSI and reg status per Round 5 finalization task.   6/19/16 released. jk 8/12/13 created for RECISTv1.1 CRF module. Jc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2593045","version":"1","preferredName":"Other Lesion Specify","preferredDefinition":"Text terms to denote an area of abnormal tissue change that is not otherwise identifed.","longName":"OTX_LES_SPEC","context":"NCIP","contextVersion":"1","type":"Non-enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"100","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[],"ConceptualDomain":{"publicId":"2008549","version":"1","preferredName":"Involvement and Extent of Disease","preferredDefinition":"indication of the presence and extent of disease.","longName":"INV_AND_EXT_OF_DZ","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22AA815-A017-5261-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2593044","version":"1","preferredName":"Other Lesion Specify","preferredDefinition":"Not otherwise specified.:(LEE-zhun) An area of abnormal tissue change.:Specify; be specific about something; define clearly.","longName":"C17649:C3824:C25685","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Lesion","conceptCode":"C3824","definition":"A localized pathological or traumatic structural change, damage, deformity, or discontinuity of tissue, organ, or body part.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Specify","conceptCode":"C25685","definition":"Be specific about something; define clearly.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"285B9A67-58AC-30F0-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-01-31","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-01-31","modifiedBy":"ONEDATA","dateModified":"2007-01-31","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"285B9A67-58BD-30F0-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-01-31","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-01-31","modifiedBy":"REEVESD","dateModified":"2007-01-31","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"7283431","version":"1","longName":"CRF CDEs","context":"AMC","ClassificationSchemeItems":[{"publicId":"7283433","version":"1","longName":"Baseline Evaluations","context":"AMC"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"If other, specify","type":"Preferred Question Text","description":"If other, specify","url":null,"context":"AMC"}],"origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"C97201CF-27E9-3976-E053-4EBD850AC2B7","latestVersionIndicator":"Yes","beginDate":"2021-08-13","endDate":null,"createdBy":"SHEIKHM","dateCreated":"2021-08-13","modifiedBy":"SHEIKHM","dateModified":"2021-09-03","changeDescription":"Curated for AMC protocol 110 MS","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}